• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘白菌素 10%溶液治疗纵向棘突甲真菌病的临床疗效。

Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes.

机构信息

Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.

Department of Dermatology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.

出版信息

J Dermatol. 2021 Oct;48(10):1474-1481. doi: 10.1111/1346-8138.16035. Epub 2021 Jul 1.

DOI:
10.1111/1346-8138.16035
PMID:34212423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8518491/
Abstract

Onychomycosis with longitudinal spikes in the nail plate has been reported to be refractory to oral drugs as with dermatophytoma. We evaluated the efficacy of 10% efinaconazole solution in the treatment of onychomycosis with longitudinal spikes. Of the 223 subjects who were enrolled in a previous study, a post-hoc analysis of 82 subjects with longitudinal spikes was performed in this study. The opacity ratio of longitudinal spikes was decreased over time from 8.1 to 0.9 at the final assessment. In addition, the longitudinal spike disappearance rate increased early after the application to 81.7% at the final assessment. Therefore, 10% efinaconazole solution can be a first-line drug for longitudinal spikes, which have been regarded as refractory to oral drugs.

摘要

甲纵向嵴伴有甲下裂片的甲真菌病与真菌性毛癣菌病一样,据报道对口服药物难治。我们评估了 10%依氟康唑溶液治疗甲纵向嵴的疗效。在之前的一项研究中,共有 223 名受试者入组,本研究对其中 82 名甲纵向嵴受试者进行了事后分析。从基线到最终评估,纵向嵴的混浊比值从 8.1 逐渐降低至 0.9。此外,在应用后的早期,纵向嵴消失率增加,最终评估时达到 81.7%。因此,10%依氟康唑溶液可作为甲纵向嵴的一线药物,这些嵴一直被认为对口服药物难治。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/7466ae7d0594/JDE-48-1474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/d0f90c1c3617/JDE-48-1474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/54df259f753d/JDE-48-1474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/f9ac2c45374d/JDE-48-1474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/7466ae7d0594/JDE-48-1474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/d0f90c1c3617/JDE-48-1474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/54df259f753d/JDE-48-1474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/f9ac2c45374d/JDE-48-1474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a160/8518491/7466ae7d0594/JDE-48-1474-g003.jpg

相似文献

1
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes.棘白菌素 10%溶液治疗纵向棘突甲真菌病的临床疗效。
J Dermatol. 2021 Oct;48(10):1474-1481. doi: 10.1111/1346-8138.16035. Epub 2021 Jul 1.
2
Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.10% 艾氟康唑外用溶液治疗甲癣的最新进展
Skin Therapy Lett. 2016 Nov;21(6):7-11.
3
Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.10% 艾氟康唑外用溶液:一种用于治疗趾甲甲真菌病的新型外用疗法的研发
J Am Podiatr Med Assoc. 2014 Nov;104(6):568-73. doi: 10.7547/8750-7315-104.6.568.
4
Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.艾氟康唑经指甲给药:其在甲癣患者指甲中的沉积及在人指甲中的体外杀菌活性。
J Drugs Dermatol. 2014 Nov;13(11):1388-92.
5
Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.10%艾氟康唑溶液局部治疗成功的皮肤癣菌瘤病例报告。
J Drugs Dermatol. 2015 May;14(5):524-6.
6
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.艾氟康唑对角蛋白的低亲和力有助于其在局部甲真菌病治疗中的指甲穿透性和杀菌活性。
Antimicrob Agents Chemother. 2014 Jul;58(7):3837-42. doi: 10.1128/AAC.00111-14. Epub 2014 Apr 21.
7
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.艾氟康唑溶液治疗趾甲甲真菌病:一项2期多中心随机双盲研究。
J Drugs Dermatol. 2013 Feb;12(2):186-92.
8
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.艾氟康唑外用溶液(10%)用于治疗成人和儿童患者的甲癣。
Expert Rev Anti Infect Ther. 2022 Jan;20(1):3-15. doi: 10.1080/14787210.2021.1939011. Epub 2021 Jun 30.
9
Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.10%艾氟康唑溶液:用于治疗趾甲甲癣的局部抗真菌疗法。
Cutis. 2013 Oct;92(4):203-8.
10
Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.10% 艾氟康唑外用溶液用于趾甲甲真菌病的局部治疗。
Expert Rev Clin Pharmacol. 2015;8(6):719-31. doi: 10.1586/17512433.2015.1083418. Epub 2015 Aug 31.

引用本文的文献

1
Beyond the screen: exploring digital health experiences of individuals affected by psoriasis - a qualitative interview study.屏幕之外:探索银屑病患者的数字健康体验——一项定性访谈研究
BMC Public Health. 2025 Sep 9;25(1):3041. doi: 10.1186/s12889-025-24401-9.
2
Onychomycosis: Old and New.甲癣:新旧情况
J Fungi (Basel). 2023 May 12;9(5):559. doi: 10.3390/jof9050559.
3
Dermatophytomas: Clinical Overview and Treatment.皮肤真菌瘤:临床概述与治疗

本文引用的文献

1
Guidelines for the management of dermatomycosis (2019).皮肤真菌病管理指南(2019年)
J Dermatol. 2020 Dec;47(12):1343-1373. doi: 10.1111/1346-8138.15618. Epub 2020 Sep 25.
2
Topical and device-based treatments for fungal infections of the toenails.用于治疗趾甲真菌感染的局部和基于器械的疗法。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD012093. doi: 10.1002/14651858.CD012093.pub2.
3
Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
J Fungi (Basel). 2022 Jul 19;8(7):742. doi: 10.3390/jof8070742.
我院10%艾氟康唑溶液和5%卢立康唑溶液治疗甲真菌病的疗效回顾性调查
Med Mycol J. 2019;60(4):95-100. doi: 10.3314/mmj.19-00009.
4
Successful Treatment of Dermatophytomas in 19 Patients Using Efinaconazole 10% Solution.使用10%艾氟康唑溶液成功治疗19例皮肤癣菌瘤
Skin Appendage Disord. 2019 Aug;5(5):304-308. doi: 10.1159/000495042. Epub 2019 Mar 20.
5
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.长期使用 10%依氟康唑溶液治疗甲真菌病患者(包括重症病例)的疗效:一项多中心、单臂研究。
J Dermatol. 2019 Aug;46(8):641-651. doi: 10.1111/1346-8138.14935. Epub 2019 Jun 17.
6
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.新型口服三唑类抗真菌药物伏立康唑赖氨酸乙酯治疗甲真菌病的疗效和安全性:一项多中心、双盲、随机 III 期研究。
J Dermatol. 2018 Oct;45(10):1151-1159. doi: 10.1111/1346-8138.14607. Epub 2018 Aug 29.
7
Topical efinaconazole: A promising therapeutic medication for tinea unguium.局部用依氟康唑:甲癣治疗的有前途的治疗药物。
J Dermatol. 2018 Oct;45(10):1225-1228. doi: 10.1111/1346-8138.14575. Epub 2018 Jul 23.
8
Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.5%卢立康唑甲用溶液治疗甲真菌病的疗效和安全性:一项多中心、双盲、随机III期研究。
J Dermatol. 2017 Jul;44(7):753-759. doi: 10.1111/1346-8138.13816. Epub 2017 Mar 23.
9
Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.10% 艾氟康唑外用溶液:一种治疗趾甲甲真菌病的新型外用疗法的制剂研发项目
J Pharm Sci. 2015 Jul;104(7):2177-82. doi: 10.1002/jps.24459. Epub 2015 May 4.
10
Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.通过独特的配方方法增强艾氟康唑在甲板下的经甲递送和扩散。
J Drugs Dermatol. 2014 Dec;13(12):1457-61.